Established a reliable biomarker in terms of postoperative adjuvant chemotherapy for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yamada, Daisaku [1 ]
Takeda, Yu [1 ]
Kobayashi, Shogo [1 ]
Sasaki, Kazuki [1 ]
Iwagami, Yoshifumi [1 ]
Tomimaru, Yoshito [1 ]
Noda, Takehiro [1 ]
Takahashi, Hidenori [1 ]
Doki, Yuichiro [1 ]
Eguchi, Hidetoshi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3309
引用
收藏
页码：2138 / 2138
页数：1
相关论文
共 50 条
  • [31] Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
    Mortier, Victor
    Wei, Felix
    Pellat, Anna
    Marchese, Ugo
    Dohan, Anthony
    Brezault, Catherine
    Barat, Maxime
    Fuks, David
    Soyer, Philippe
    Coriat, Romain
    CANCERS, 2022, 14 (24)
  • [32] Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
    Chikhladze, Sophia
    Lederer, Ann-Kathrin
    Kousoulas, Lampros
    Reinmuth, Marilena
    Sick, Olivia
    Fichtner-Feigl, Stefan
    Wittel, Uwe A.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (01)
  • [33] Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: Continue or stop?
    Ren, Fang
    Xu, Ying-Chun
    Wang, Hong-Xia
    Tang, Lei
    Ma, Yue
    PANCREATOLOGY, 2012, 12 (02) : 162 - 169
  • [34] Biomarker Discovery and Molecular Imaging of Pancreatic Ductal Adenocarcinoma
    Kelly, K.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [35] MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
    Ding, Feng
    Zhang, Shuang
    Gao, Shaoyang
    Shang, Jian
    Li, Yanxia
    Cui, Ning
    Zhao, Qiu
    ONCOTARGET, 2017, 8 (38) : 64224 - 64236
  • [36] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [37] An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
    Makler, Amy
    Narayanan, Ramaswamy
    Asghar, Waseem
    BIOSENSORS-BASEL, 2022, 12 (10):
  • [38] Tissue transglutaminase II: A biomarker of pancreatic ductal adenocarcinoma
    Yang, GY
    Dilworth, HP
    Ashfaq, R
    Hruban, RH
    Maitra, A
    MODERN PATHOLOGY, 2005, 18 : 290A - 290A
  • [39] Tissue transglutaminase II: A biomarker of pancreatic ductal adenocarcinoma
    Yang, GY
    Dilworth, HP
    Ashfaq, R
    Hruban, RH
    Maitra, A
    LABORATORY INVESTIGATION, 2005, 85 : 290A - 290A
  • [40] Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
    Liu, Han
    Sun, Bo
    Wang, Shengnan
    Liu, Congjin
    Lu, Yun
    Li, Ding
    Liu, Xingdang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (01) : 373 - 382
12345